|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07D 401/06 | |
| A61K 31/4709 |
| (11) | Number of the document | 2697215 |
| (13) | Kind of document | T |
| (96) | European patent application number | 12706221.4 |
| Date of filing the European patent application | 2012-02-14 | |
| (97) | Date of publication of the European application | 2014-02-19 |
| (45) | Date of publication and mention of the grant of the patent | 2017-11-22 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/EP2012/052504 |
| Date | 2012-02-14 |
| (87) | Number | WO 2012/119841 |
| Date | 2012-09-13 |
| (30) | Number | Date | Country code |
| 201103837 | 2011-03-07 | GB |
| (72) |
BETANCOURT, Aimesther, CA
LEMIEUX, Marc, CA
THIBERT, Roch, CA
|
| (73) |
Atopix Therapeutics Limited,
265 Strand, London WC2R 1BH,
GB
|
| (54) | AMORPHOUS (5-FLUORO-2-METHYL-3-QUINOLIN-2-YLMETHYL-INDOL-1-YL)-ACETIC ACID |
| AMORPHOUS (5-FLUORO-2-METHYL-3-QUINOLIN-2-YLMETHYL-INDOL-1-YL)-ACETIC ACID |